Multidrug resistant typhoid fever: therapeutic considerations.
Indian Pediatr
;
1992 Apr; 29(4): 443-8
Artículo
en Inglés
| IMSEAR
| ID: sea-14448
ABSTRACT
Forty six blood culture positive cases were studied during the current outbreak of multidrug resistant typhoid fever (MRTF). The present outbreak was caused by E1 phage type and organisms were resistant to all commonly used drugs for the treatment of typhoid fever, viz., chloramphenicol (78%), co-trimoxazole (76%) and ampicillin (68%). Treatment failures with chloramphenicol (45.5%) corroborated well with in vitro resistance. No treatment failure was seen with chloramphenicol and ceftriaxone, when these drugs were used in cases infected with sensitive strains. Among the alternative drugs used in cases with in vitro sensitivity, successful clinical response was seen with ceftriaxone (4/4) and cefotaxime (8/9) as compared to cephalexin (3/5) or a combination of cephalexin and furazolidone (9/12).
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Fagos de Salmonella
/
Salmonella typhi
/
Fiebre Tifoidea
/
Población Urbana
/
Humanos
/
Farmacorresistencia Microbiana
/
Resistencia a la Ampicilina
/
Resistencia al Cloranfenicol
/
Resistencia a la Tetraciclina
/
Resistencia al Trimetoprim
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian Pediatr
Año:
1992
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS